Genus plc Stock
The Genus plc stock is trending slightly upwards today, with an increase of €0.20 (0.570%) compared to yesterday's price.
Pros and Cons of Genus plc in the next few years
Pros
?
S********** s********
?
W********* I********* f** t** n*** y****
?
B****
Cons
?
C******** o* t** e**********
?
M***** P*******
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Genus plc vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Genus plc | 0.570% | 4.142% | 19.728% | 55.752% | 19.728% | 10.692% | -42.295% |
| Ironwood Pharmaceuticals | -1.590% | 0.000% | 9.945% | 93.204% | 49.624% | -62.059% | -53.176% |
| Novocure Ltd | -1.760% | -6.977% | -12.383% | -56.999% | -13.542% | -88.765% | -93.301% |
| Iovance Biotherapeutics Inc. | -1.190% | -10.557% | -3.890% | -63.095% | -13.027% | -72.114% | -94.924% |
Comments
Genus (OTCMKTS:GENSF) had its "buy" rating reaffirmed by analysts at Deutsche Bank Aktiengesellschaft.
Show more
Ratings data for GENSF provided by MarketBeat